C-Myc And Bcl-2 Expression In Supraglottic Squamous Cell Carcinoma of the Larynx

Abstract

OBJECTIVES: To evaluate the expression and prognostic significance of c-myc and bcl-2 oncogenes in squamous cell carcinoma (SCC) of the supraglottic larynx.

STUDY DESIGN: A retrospective cohort study of 61 patients who underwent surgery for SCC of the supraglottic larynx. Gender, age, TNM status, operative procedure, recurrences, and disease-free survival periods were recorded.

METHODS: Hematoxylin and eosin-stained sections were reexamined for grade, invasion of tumor margins, lymphovascular invasion, lymphocyte infiltration, and perineural invasion. Immunohistochemical detection of c-myc and bcl-2 oncogenes was performed using monoclonal antibodies.

RESULTS: No correlation was observed between either c-myc or bcl-2 and the clinical and histopathologic parameters. Survival analysis revealed no correlation of either c-myc (P = 0.88) or bcl-2 (P = 0.85) with the disease-free survival. c-myc expression was found to be significantly higher in bcl-2-positive patients (P = 0.001).

CONCLUSION: Neither c-myc nor bcl-2 had shown to be prognostic factor for laryngeal carcinoma in this present study. Correlation between c-myc and bcl-2 supports the experimental observations of cooperative action between these two genes in tumorigenesis.

Get full access to this article

View all access options for this article.

References

Sarac

Ayhan

Hosal

, et al. Prognostic significance of PCNA expression in laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998;124:1321–4.

Gapany

Pavelic

Kelley

, et al. Immunohistochemical detection of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg 1994;120:255–9.

Porter

Field

Leung

, et al. The detection of the c-myc and Ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 1994;114:105–9.

Miyazaki

Sasno

Shiga

, et al. Analysis of c-myc oncogene in human esophageal carcinoma: Immunohistochemistry, in situ hybridization and Northern and Southern blot studies. Anticancer Res 1992;12:1747–56.

Haughey

Von Hoff

Windle

, et al. c-myc oncogene copy number in squamous carcinoma of the head and neck. Am J Otolaryngol 1992;13:168–71.

Osmak

Beketic-Oreskovic

Matulic

, et al. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes. Mutat Res 1993;303:113–20.

Takes

Baatenburg de Jong

Schuuring

, et al. Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1997;123:412–9.

Sakai

Kawano

Okamura

, et al. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J Oral Pathol Med 1990;19:1–4.

Friedman

Grey

Venkatesan

, et al. Prognostic significance of bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 1997;106:445–50.

10.

Sarbia

Bittinger

Porschen

, et al. Bcl-2 expression and prognosis in squamous cell carcinomas of the esophagus. Int J Cancer 1996;69:324–8.

11.

Patel

Bhatavdekar

Chikhlikar

, et al. Clinical significance of p53, nm23, and bcl-2 in T3-4 N1M0 oesophageal carcinoma: An immunohistochemical approach. J Surg Oncol 1997;65:111–6.

12.

Ohbu

Saegusa

Kobayashi

, et al. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 1997;79:1287–93.

13.

Spafford

Koeppe

Pan

, et al. Correlation of tumor markers p53, bcl-2, CD34, Cd44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:627–32.

14.

Whisler

Wood

Caldarelli

, et al. Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope 1998;108:630–8.

15.

Klatka

Rolinski

Kupisz

, et al. Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 1999;256:299–302.

16.

Jackel

Sellmann

Dorudian

, et al. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Laryngoscope 2000;110:1339–45.

17.

Hotz

Bosq

Zbaeren

, et al. Spontaneous apoptosis and the expression of p-53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:417–22.

18.

Fanidi

Harrington

Evan

Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992;359:554–6.

19.

Bissonnette

Echeverri

Mahboubi

, et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552–4.

20.

Sarbia

Loberg

Wolter

, et al. Expression of bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. Am J Pathol 1999;155:1027–32.

21.

Wang

Liu

Johnston

, et al. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis. Am J Pathol 1998;152:1407–11.